October 28, 2026
Ten years ago, Dr. Traynelis hoped his research might one day lead to personalized treatments for children with GRIN-related epilepsies. Today, that vision is helping shape a late-stage clinical trial and more.
February 19, 2026
CDEs provide universal “sheet music” for epilepsy research, providing a standardized way of describing and collecting data.
July 28, 2025
Drug repurposing fast-tracks treatments for epilepsy
March 24, 2025
Brain organoids grown from human cells offer insights into rare epilepsies.
November 20, 2024
To really move the needle on SUDEP research, we need to bridge two key topics: advancing our understanding of SUDEP risk through existing data and leveraging that knowledge to develop tools that help individuals and healthcare providers better understand and communicate risk.
October 09, 2024
A humble side project has developed into a potential curative treatment on the cusp of human clinical trials, thanks to CURE Epilepsy funding.
July 08, 2024
Captain Jack Somers was familiar with operating in stealth mode, hidden from enemies. But unbeknownst to him, similarly covert changes were taking root in his brain after a particularly close grenade blast experienced in 2010 while serving overseas.
March 11, 2024
These genes included some known FCD genes, as well as six new genes that could also contribute to FCD.
December 01, 2023
CURE Epilepsy has long been leading the charge in funding research on seizure-related biomarkers and is committed to advancing this research as it will have the potential to improve outcomes for people with epilepsy by identifying, for example, who may be at risk for epilepsy after a stroke to who may be at risk for epilepsy following a brain injury to who may not respond to antiseizure medications.
